Last reviewed · How we verify

NCT06631794: HPV-ADO

Evaluation of the Impact of a HPV Vaccination Talk with Third Grade Students

Not yet recruiting Last updated 8 October 2024
What this trial tests

trial testing A short talk about the importance of HPV vaccination in Teenagers in 1,170 participants. Not yet recruiting.

Timeline
23 October 2024
Primary endpoint
23 April 2025
1 October 2025

Quick facts

Lead sponsorHopital Foch
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment1,170
Start date23 October 2024
Primary completion23 April 2025
Estimated completion1 October 2025

Drugs / interventions tested

Conditions studied

Sponsor

Hopital Foch — full company profile →

Who can join

Adults 14 to 14, any sex, with Teenagers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective pragmatic study to assess the impact of a HPV vaccination talk in secondary school on actual vaccine dispensing in test communes compared with control communes. The talk consist on a briefing on the importance of vaccination. This is a controlled study, since two communes will benefit from the HPV vaccination talk, while the other two will serve as controls without set up of the HPV vaccination talk. The set up of this presentation will be open-label.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Hopital Foch trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06631794.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing